Zacks: Analysts Expect Tivity Health, Inc. (NASDAQ:TVTY) Will Post Quarterly Sales of $135.00 Million

Wall Street brokerages predict that Tivity Health, Inc. (NASDAQ:TVTY – Get Rating) will announce sales of $135.00 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Tivity Health’s earnings. The lowest sales estimate is $132.80 million and the highest is $139.10 million. Tivity Health posted sales of $120.07 million during the same quarter last year, which suggests a positive year-over-year growth rate of 12.4%. The company is expected to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Tivity Health will report full year sales of $552.25 million for the current financial year, with estimates ranging from $541.19 million to $565.73 million. For the next financial year, analysts forecast that the company will report sales of $613.20 million, with estimates ranging from $596.01 million to $636.27 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Tivity Health.

Tivity Health (NASDAQ:TVTY – Get Rating) last issued its quarterly earnings results on Thursday, May 5th. The company reported $0.40 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.02). Tivity Health had a return on equity of 75.94% and a net margin of 17.25%. The company had revenue of $127.51 million during the quarter, compared to analysts’ expectations of $132.21 million. During the same period last year, the firm posted $0.40 earnings per share. Tivity Health’s quarterly revenue was up 18.0% compared to the same quarter last year.

Several research firms have weighed in on TVTY. Barrington Research downgraded shares of Tivity Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 5th. StockNews.com initiated coverage on shares of Tivity Health in a research report on Thursday, March 31st. They set a “hold” rating on the stock. William Blair reiterated a “market perform” rating on shares of Tivity Health in a research note on Thursday, February 24th. Zacks Investment Research cut Tivity Health from a “hold” rating to a “sell” rating in a research note on Tuesday. Finally, Credit Suisse Group upped their price objective on Tivity Health from $29.00 to $31.00 and gave the company a “neutral” rating in a research report on Friday, March 11th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Tivity Health has a consensus rating of “Hold” and a consensus target price of $30.67.

TVTY opened at $31.87 on Friday. Tivity Health has a one year low of $21.25 and a one year high of $32.89. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.47 and a quick ratio of 2.24. The firm has a market capitalization of $1.59 billion, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 1.76 and a beta of 2.14. The company has a fifty day moving average price of $31.31 and a 200-day moving average price of $27.78.

A number of institutional investors have recently bought and sold shares of TVTY. National Bank of Canada FI purchased a new position in shares of Tivity Health during the 4th quarter valued at approximately $28,000. O Shaughnessy Asset Management LLC acquired a new position in Tivity Health in the 3rd quarter valued at about $39,000. Advisor Group Holdings Inc. increased its holdings in Tivity Health by 9.1% in the 1st quarter. Advisor Group Holdings Inc. now owns 4,106 shares of the company’s stock valued at $133,000 after purchasing an additional 342 shares during the last quarter. Mutual of America Capital Management LLC lifted its position in shares of Tivity Health by 9.3% during the 3rd quarter. Mutual of America Capital Management LLC now owns 5,892 shares of the company’s stock worth $136,000 after purchasing an additional 503 shares during the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Tivity Health by 59.1% in the 3rd quarter. Royal Bank of Canada now owns 6,386 shares of the company’s stock valued at $147,000 after acquiring an additional 2,373 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

About Tivity Health (Get Rating)

Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.

See Also